BioSpace News Archive

Albany Molecular Research, Inc., ( AMRI ), a leading global provider of advanced contract research, development and manufacturing solutions, today announced that its CEO and CFO will present a corporate overview at the Jefferies 2020 Virtual London Healthcare Conference. The presentation, to be delivered by CEO John Ratliff and CFO Jason Knoblauch , will be recorded and made available on AMRI’s website. AMRI’s execu

Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rare pediatric diseases, today announced the pricing of an underwritten public offering of 2,800,000 shares of its common stock at a price to the public of $7.00 per share, for gross proceeds of $19.6 million. The Company has also granted the underwriters a 45-day option to purchase, at the same price

Company Strengthens its Regulatory and Quality Capabilities to Support Mytesi® Commercial Markets as Well as Ongoing Clinical Studies Including the Pivotal Phase 3 Trial for Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Therapy

PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“PRIMO” or the “Company”) Primo Nutraceuticals Inc. has entered intoa non-binding letter of intent (the “LOI”) with MedCanBiotechnologies Inc. (“MEDCAN BIOTECH”).

Aiforia, a leading provider of deep learning artificial intelligence (AI) solutions for image analysis across a variety of medical domains, has been granted U.S. Patent No. 10,803,586 by the United States Patent and Trademark Office (USPTO).

Summa Equity , the purpose-driven private equity firm that invests to solve global challenges, has acquired a majority stake in Sengenics , a functional proteomics company with a proprietary technology called KREX that enables researchers to vastly improve the understanding of the human proteome and immune system. Proteomics, i.e. the large-scale study of proteins, is one of the most important areas for gaining insights into h

Neoadjuvant, or pre-surgical, combination treatment with the immune checkpoint inhibitors tremelimumab (anti-CTLA-4) and durvalumab (anti-PD-1) was well-tolerated and showed early signs of activity in certain patients with localized bladder cancer who do not have standard treatment options available, according to a Phase I clinical trial conducted by The University of Texas MD Anderson Cancer Center.

There has been much criticism of the President who has openly decried the use of aborted fetal material in scientific research, for allowing Regeneron’s antibody product and remdesivir to be used in his COVID-19 treatment

GenomOncology announced today the release of their newest version of the GenomOncology (GO) Pathology Workbench solution, which is optimized for larger panels (such as Illumina’s TSO500), higher sample throughput, and the interpretation of copy numbers and structural variants by Next Generation Sequencing (NGS)

The global leader in tech wellness partners with clinically reliable wearable to validate the efficacy of its cutting-edge percussive massage technology